| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...729108B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0029108 |
| P932 | PMC publication ID | 3250395 |
| P698 | PubMed publication ID | 22235262 |
| P5875 | ResearchGate publication ID | 221738591 |
| P50 | author | Richard M. Anthony | Q56191657 |
| Paul Klatser | Q56685649 | ||
| Indra L Bergval | Q114441564 | ||
| Anja R J Schuitema | Q114441565 | ||
| Dick van Soolingen | Q47087451 | ||
| P2093 | author name string | Kristin Kremer | |
| Brian Kwok | |||
| P2860 | cites work | The past and future of tuberculosis research | Q21559415 |
| High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography | Q21563563 | ||
| Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
| Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis | Q24624866 | ||
| Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency | Q24814339 | ||
| Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 | ||
| Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa | Q28272340 | ||
| Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis | Q28469011 | ||
| Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment | Q28478602 | ||
| Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology | Q29615131 | ||
| Darwinian evolution can follow only very few mutational paths to fitter proteins | Q29616042 | ||
| Molecular determinants of drug resistance in tuberculosis. | Q30326258 | ||
| The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis | Q33325926 | ||
| Positive epistasis drives the acquisition of multidrug resistance | Q33486486 | ||
| Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany | Q33858360 | ||
| Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis | Q33885134 | ||
| Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. | Q33962045 | ||
| Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates | Q33970864 | ||
| Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community | Q33971262 | ||
| Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. | Q33977319 | ||
| Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv | Q33980958 | ||
| Fitness cost of chromosomal drug resistance-conferring mutations | Q34107494 | ||
| Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. | Q34131132 | ||
| Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP se | Q34303290 | ||
| The population structure of Mycobacterium bovis in Great Britain: clonal expansion | Q34394463 | ||
| Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. | Q34973711 | ||
| Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate | Q34975227 | ||
| The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. | Q34999398 | ||
| Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis | Q35006529 | ||
| Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection | Q35006626 | ||
| The effect of drug resistance on the fitness of Mycobacterium tuberculosis | Q35035354 | ||
| Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis | Q35872892 | ||
| Rifampicin resistance in tuberculosis outbreak, London, England | Q36009343 | ||
| Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis spoligotype family | Q36539815 | ||
| Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. | Q36797710 | ||
| Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance. | Q36932942 | ||
| Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. | Q53442441 | ||
| Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. | Q53883061 | ||
| Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands | Q59362502 | ||
| Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands | Q59362511 | ||
| Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia | Q80085711 | ||
| Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites | Q81564110 | ||
| Mapping the fitness of Mycobacterium tuberculosis strains: a complex picture | Q84773910 | ||
| Predicting antibiotic resistance | Q37002813 | ||
| Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness | Q37120860 | ||
| Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. | Q37133287 | ||
| Major Mycobacterium tuberculosis lineages associate with patient country of origin | Q37156812 | ||
| Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers | Q37511376 | ||
| Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. | Q37675095 | ||
| Compensation of fitness costs and reversibility of antibiotic resistance mutations | Q37696851 | ||
| Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH. | Q38435339 | ||
| Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance | Q38905383 | ||
| Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis. | Q38905387 | ||
| Specific mutations in the Mycobacterium tuberculosis rpoB gene are associated with increased dnaE2 expression | Q38905392 | ||
| Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone | Q39399524 | ||
| The competitive cost of antibiotic resistance in Mycobacterium tuberculosis | Q40311130 | ||
| Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis | Q40572948 | ||
| Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants | Q42550095 | ||
| The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale | Q43260011 | ||
| Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs | Q43891804 | ||
| Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance | Q44144059 | ||
| The evolution of drug resistance in Mycobacterium tuberculosis: from a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population | Q46580370 | ||
| Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia | Q47409707 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| rifampicin | Q422652 | ||
| isoniazid | Q423169 | ||
| P304 | page(s) | e29108 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Pre-existing isoniazid resistance, but not the genotype of Mycobacterium tuberculosis drives rifampicin resistance codon preference in vitro | |
| P478 | volume | 7 |
| Q39682367 | An altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance |
| Q39038482 | Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. |
| Q28731573 | Bead array direct rRNA capture assay (rCapA) for amplification free speciation of Mycobacterium cultures |
| Q27016579 | Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy |
| Q33595994 | Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance |
| Q38144839 | Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. |
| Q42968654 | Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure |
| Q40511732 | Mycobacterium tuberculosis Beijing type mutation frequency |
| Q33896434 | Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia |
| Q37538786 | Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies |
| Q36675409 | The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis |
| Q37683485 | The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin? |
| Q28547769 | Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation |
Search more.